Clinical trial
Post-Market Clinical Follow-up Study on SMILE Treatment of Myopia With and Without Astigmatism by VISUMAX 800
NCT04884672 is registered in ClinicalTrials.gov with Carl Zeiss Meditec AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Market Clinical Follow-up Study on SMILE Treatment of Myopia With and Without Astigmatism by VISUMAX 800
- Lead sponsor
- Carl Zeiss Meditec AG
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 9, 2021
- Completion date
- March 25, 2023
- Enrollment
- 237 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.